Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Giacomini

Showing results (161-170 of 177) with videos related to

Pageof 18
Sort By:
Human Immunology|April 1, 1996
Distinctive features of the alpha 1-domain alpha helix of HLA-C heavy chains free of beta 2-microglobulinA Setini, A Beretta, C De Santis, et al.
Experimental Neurology|February 13, 2001
Microdialysis in Parkinsonian patient basal ganglia: acute apomorphine-induced clinical and electrophysiological effects not paralleled by changes in the release of neuroactive amino acidsE Fedele, P Mazzone, A Stefani, et al.
Cancer Research|September 19, 2007
Genomic profiling reveals alternative genetic pathways of prostate tumorigenesisJacques Lapointe, Chunde Li, Craig P Giacomini, et al.
Anticancer Research|July 1, 1986
Effect of recombinant human fibroblast interferon and mezerein on growth, differentiation, immune interferon binding and tumor associated antigen expression in human melanoma cellsP B Fisher, H Hermo, W E Solowey, et al.
Tissue Antigens|February 11, 1998
HLA-C heavy chains free of beta2-microglobulin: distribution in normal tissues and neoplastic lesions of non-lymphoid origin and interferon-gamma responsivenessP Giacomini, A Beretta, M R Nicotra, et al.
Tissue Antigens|August 25, 2000
Melanomas and melanoma cell lines do not express HLA-G, and the expression cannot be induced by gammaIFN treatmentG Frumento, S Franchello, G L Palmisano, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2012
CDX2 is an amplified lineage-survival oncogene in colorectal cancerKeyan Salari, Mary E Spulak, Justin Cuff, et al.
Cancer Research|June 11, 1999
Low prevalence of selective human leukocyte antigen (HLA)-A and HLA-B epitope losses in early-passage tumor cell linesP Giacomini, E Giorda, R Fraioli, et al.
The American Journal of Surgical Pathology|January 29, 2008
hCAP-D3 expression marks a prostate cancer subtype with favorable clinical behavior and androgen signaling signatureJacques Lapointe, Sameer Malhotra, John P Higgins, et al.
In Vivo (Athens, Greece)|May 6, 2009
Hyperthermic isolated perfusion with tumor necrosis factor-alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcoma: the experience of the Italian Society of Integrated Locoregional Treatment in Oncology (SITILO)F Di Filippo, P Giacomini, C R Rossi, et al.
Pageof 18

Showing results (161-170 of 177) with videos related to

Sort By:
Pageof 18
Human Immunology|April 1, 1996
Distinctive features of the alpha 1-domain alpha helix of HLA-C heavy chains free of beta 2-microglobulinA Setini, A Beretta, C De Santis, et al.
Experimental Neurology|February 13, 2001
Microdialysis in Parkinsonian patient basal ganglia: acute apomorphine-induced clinical and electrophysiological effects not paralleled by changes in the release of neuroactive amino acidsE Fedele, P Mazzone, A Stefani, et al.
Cancer Research|September 19, 2007
Genomic profiling reveals alternative genetic pathways of prostate tumorigenesisJacques Lapointe, Chunde Li, Craig P Giacomini, et al.
Anticancer Research|July 1, 1986
Effect of recombinant human fibroblast interferon and mezerein on growth, differentiation, immune interferon binding and tumor associated antigen expression in human melanoma cellsP B Fisher, H Hermo, W E Solowey, et al.
Tissue Antigens|February 11, 1998
HLA-C heavy chains free of beta2-microglobulin: distribution in normal tissues and neoplastic lesions of non-lymphoid origin and interferon-gamma responsivenessP Giacomini, A Beretta, M R Nicotra, et al.
Tissue Antigens|August 25, 2000
Melanomas and melanoma cell lines do not express HLA-G, and the expression cannot be induced by gammaIFN treatmentG Frumento, S Franchello, G L Palmisano, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2012
CDX2 is an amplified lineage-survival oncogene in colorectal cancerKeyan Salari, Mary E Spulak, Justin Cuff, et al.
Cancer Research|June 11, 1999
Low prevalence of selective human leukocyte antigen (HLA)-A and HLA-B epitope losses in early-passage tumor cell linesP Giacomini, E Giorda, R Fraioli, et al.
The American Journal of Surgical Pathology|January 29, 2008
hCAP-D3 expression marks a prostate cancer subtype with favorable clinical behavior and androgen signaling signatureJacques Lapointe, Sameer Malhotra, John P Higgins, et al.
In Vivo (Athens, Greece)|May 6, 2009
Hyperthermic isolated perfusion with tumor necrosis factor-alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcoma: the experience of the Italian Society of Integrated Locoregional Treatment in Oncology (SITILO)F Di Filippo, P Giacomini, C R Rossi, et al.
Pageof 18